What question did this study set out to answer?

To evaluate the significance of the C-reactive protein to albumin ratio as a prognostic marker in renal cell carcinoma patients.

January 24, 2026Annals of Medicine5 citationsOpen Access

Elevated C-reactive protein to albumin ratio is a promising predictive biomarker for prognosis in patients with renal cell carcinoma

To evaluate the significance of the C-reactive protein to albumin ratio as a prognostic marker in renal cell carcinoma patients.
Analyzed data from patients diagnosed with renal cell carcinoma (RCC)
Measured levels of C-reactive protein and albumin
Assessed the correlation between CAR and patient outcomes
Elevated CAR strongly predicts poor prognosis in RCC patients
Higher CAR is linked to increased risk of recurrence
Findings support CAR as a valuable biomarker for clinical decision-making

Our findings indicate that an elevated CAR serves as a strong predictor of poor prognosis or recurrence in patients with RCC.

Perguntar à IA

Bookmark

View Full Paper

Xu et al. (Wed,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Perguntar à IA

Bookmark

View Full Paper